PentaBase ApS is a privately held company founded in 2006, having roots back to the invention Intercalating Nucleic Acid, INA®, made by the founder of PentaBase, Ulf B. Christensen and published in 2002 [Christensen UB and Pedersen EB, Nucl. Acid. Res., 2002, 30, 4918-4925]. Today PentaBase has refined INA®, and made it compatible with standard, open platform instruments used in most molecular biology facilities around the world. We call the proprietary monomers in our updated INA for “pentabases”. Using pentabases in oligonucleotides allows one to make products that are often out-performing comparable products based on standard DNA or other DNA analogues. PentaBase modified oligos also comprise new and unique features, allowing for alternative approaches in addressing challenges in analysis or manipulation of genetic material. We have therefore made custom oligonucleotides comprising pentabases available for researchers around the world. If you have a challenge in genetic analysis, then talk to us. Furthermore, we have used our platform technology for developing own assays and services mainly based on real-time PCR.
The PentaBase team, 2017